Incyte Corp. sell BMO Capital Markets
Start price
15.06.26
/
50%
€88.84
Target price
15.06.27
-
Performance (%)
16.67%
Price
31.07.26
€103.65
Summary
This prediction is currently active. The SELL prediction by BMO_Capital_Markets currently has a performance of 16.67%. This prediction currently runs until 15.06.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Incyte Corp. | 0.145% | 0.145% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte (INCY) had its "underperform" rating reaffirmed by BMO Capital Markets.
Ratings data for INCY provided by MarketBeat